Fig. 4From: Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similarCD8-staining of a PT and the corresponding R (a) PT,CD8 percentage 10% (b) R, CD8 percentage 3%Back to article page